Table 7 Univariate models of cost and medical personnel utilization per patient that remained in care for one full year (n = 169)

Hospitalized during ART (n = 8)

1.79

(1.40, 2.28)

<0.0001

ART changed due to side effects (n = 21)

1.35

(1.15, 1.59)

0.0002

Treated for TB (n = 20)

1.2

(1.02, 1.43)

0.0276

CDC Stage C (n = 98)

1.14

(1.02, 1.27)

0.0199

Physician time

Relative difference

95% CI

p-value

Treated for TB (n = 20)

1.83

(1.52, 2.21)

<0.0001

ART changed due to side effects (n = 21)

1.36

(1.01, 1.87)

<0.0001

CDC Stage C (n = 98)

1.35

(1.18, 1.54)

<0.0001

No income (n = 94)

1.21

(1.06, 1.39)

0.0046

Hemoglobin <10 mg/dl at baseline (n = 44)

1.18

(1.01, 1.38)

0.0321

Body weight in the bottom quartile at baseline (n = 33)

1.19

(1.01, 1.41)

0.0479

Female gender (n = 94)

1.16

(1.01, 1.33)

0.0301

Nurse time

Relative difference

95% CI

p-value

Treated for TB (n = 20)

2.00

(1.70, 2.33)

<0.0001

ART changed due to side effects (n = 21)

1.21

(1.01, 1.46)

0.0437

CDC Stage C (n = 98)

1.18

(1.04, 1.33)

0.0309